Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by Mbxwatcheron May 17, 2023 12:29pm
130 Views
Post# 35452678

RE:RE:National Bank (house 80) is back at it

RE:RE:National Bank (house 80) is back at itTo be sure I am nobody's oracle.

However, I think this was to be expected, and I did try to point this out on an earlier post when I stated we might all be surprised by the market's muted reaction to our announcements after this period.

It is clear to me, on this board that strong believers have been shaken.
I had a very hard time yesterday listenting to the " VTM would be a great investment if we never sold another vial c*rap".  We were projecting tens of millions in sales on this part of the business, and using pre-pandemic numbers to justify it..........by we I mean the company.

Really the same goes for QAPS.  That QAPS sales were down year over year last quarter is mind boggling to me.  As is the fact that we still have only one major deal, that has not kicked in yet.

This company does not provide guidance.  Investors are left to 'parse' the statments management makes on the webcasts, and I think the investor base is very very tired.

I love yesterday's announcement, and frankly do believe we will get more QAPS announcements in the future.  It is the way of Healthcare.   But I think the share price will be very slow to reflect near term wins and announcements, until the proof exists on the income statement.  

In other words I think the muted reaction is management being held to acount for past statments.
<< Previous
Bullboard Posts
Next >>